|
1
|
Haanpää M, Attal N, Backonja M, Baron R,
Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA,
Iannetti GD, et al: NeuPSIG guidelines on neuropathic pain
assessment. Pain. 152:14–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jensen TS, Baron R, Haanpää M, Kalso E,
Loeser JD, Rice AS and Treede RD: A new definition of neuropathic
pain. Pain. 152:2204–2205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cruccu G and Truini A: A review of
neuropathic pain: From guidelines to clinical practice. Pain Ther.
6 Suppl 1:35–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Amato F, Duse G, Consoletti L, Lo Presti
C, Firetto V, Ciliberto G, Parigi LA, Palmieri V and Mazza M:
Efficacy and safety of 5% lidocaine-medicated plasters in localized
pain with neuropathic and/or inflammatory characteristics: An
observational, real-world study. Eur Rev Med Pharmacol Sci.
21:4228–4235. 2017.PubMed/NCBI
|
|
5
|
O'Connor AB and Dworkin RH: Treatment of
neuropathic pain: An overview of recent guidelines. Am J Med. 122
Suppl:S22–S32. 2009. View Article : Google Scholar
|
|
6
|
Horváth G, Gölöncsér F, Csölle C, Király
K, Andó RD, Baranyi M, Koványi B, Máté Z, Hoffmann K, Algaier I, et
al: Central P2Y12 receptor blockade alleviates inflammatory and
neuropathic pain and cytokine production in rodents. Neurobiol Dis.
70:162–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishikawa T, Miyagi M, Kamoda H, Orita S,
Eguchi Y, Arai G, Suzuki M, Sakuma Y, Oikawa Y, Inoue G, et al:
Differences between tumor necrosis factor-α receptors types 1 and 2
in the modulation of spinal glial cell activation and mechanical
allodynia in a rat sciatic nerve injury model. Spine. 38:11–16.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lefèvre Y, Amadio A, Vincent P,
Descheemaeker A, Oliet SH, Dallel R and Voisin DL: Neuropathic pain
depends upon D-serine co-activation of spinal NMDA receptors in
rats. Neurosci Lett. 603:42–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tiwari V, Guan Y and Raja SN: Modulating
the delicate glial-neuronal interactions in neuropathic pain:
Promises and potential caveats. Neurosci Biobehav Rev. 45:19–27.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bolay H and Moskowitz MA: Mechanisms of
pain modulation in chronic syndromes. Neurology. 59 Suppl 2:S2–S7.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawasaki Y, Zhang L, Cheng JK and Ji RR:
Cytokine mechanisms of central sensitization: Distinct and
overlapping role of interleukin-1beta, interleukin-6, and tumor
necrosis factor-alpha in regulating synaptic and neuronal activity
in the superficial spinal cord. J Neurosci. 28:5189–5194. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Finnerup NB, Attal N, Haroutounian S,
McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P,
Jensen TS, et al: Pharmacotherapy for neuropathic pain in adults: A
systematic review and meta-analysis. Lancet Neurol. 14:162–173.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jia HB, Jin Y, Ji Q, Hu YF, Zhou ZQ, Xu JG
and Yang JJ: Effects of recombinant human erythropoietin on
neuropathic pain and cerebral expressions of cytokines and nuclear
factor-kappa B. Can J Anaesth. 56:597–603. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Fu ZJ, Sun T, Zhao XL, Song WG,
Jia MR and Wei GF: Expression of NF-kappaB and TNF-alpha in spinal
dorsal horn in a rat model of neuropathic pain. Zhonghua Yi Xue Za
Zhi. 90:1067–1071. 2010.(In Chinese). PubMed/NCBI
|
|
15
|
Song XJ, Wang ZB, Gan Q and Walters ET:
cAMP and cGMP contribute to sensory neuron hyperexcitability and
hyperalgesia in rats with dorsal root ganglia compression. J
Neurophysiol. 95:479–492. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cenac N, Altier C, Chapman K, Liedtke W,
Zamponi G and Vergnolle N: Transient receptor potential vanilloid-4
has a major role in visceral hypersensitivity symptoms.
Gastroenterology. 135:937–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cenac N, Altier C, Motta JP, d'Aldebert E,
Galeano S, Zamponi GW and Vergnolle N: Potentiation of TRPV4
signalling by histamine and serotonin: An important mechanism for
visceral hypersensitivity. Gut. 59:481–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Facer P, Casula MA, Smith GD, Benham CD,
Chessell IP, Bountra C, Sinisi M, Birch R and Anand P: Differential
expression of the capsaicin receptor TRPV1 and related novel
receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and
changes in traumatic and diabetic neuropathy. BMC Neurol. 7:112007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tung KW, Behera D and Biswal S:
Neuropathic pain mechanisms and imaging. Semin Musculoskelet
Radiol. 19:103–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cervantes-Durán C, Vidal-Cantú GC,
Godínez-Chaparro B and Granados-Soto V: Role of spinal 5-HT2
receptors subtypes in formalin-induced long-lasting
hypersensitivity. Pharmacol Rep. 68:434–442. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Madishetti S, Schneble N, König C, Hirsch
E, Schulz S, Müller JP and Wetzker R: PI3Kγ integrates cAMP and Akt
signalling of the μ-opioid receptor. Br J Pharmacol. 171:3328–3337.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Manet R, Fabre N, Moyse E, Laurent B and
Schmidt EA: Intracranial hypertension is painless! Acta Neurochir
Suppl (Wien). 122:275–277. 2016. View Article : Google Scholar
|
|
23
|
Wu J, Xu Y, Pu S, Jiang W and Du D:
p38/MAPK inhibitor modulates the expression of dorsal horn GABA(B)
receptors in the spinal nerve ligation model of neuropathic pain.
Neuroimmunomodulation. 18:150–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Zheng H, Zhu HY, Hu S, Wang S,
Jiang X and Xu GY: Acute effects of transforming growth
factor-beta1 on neuronal excitability and involvement in the pain
of rats with chronic pancreatitis. J Neurogastroenterol Motil.
22:333–343. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Komiya Y and Habas R: Wnt signal
transduction pathways. Organogenesis. 4:68–75. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davis EK, Zou Y and Ghosh A: Wnts acting
through canonical and noncanonical signaling pathways exert
opposite effects on hippocampal synapse formation. Neural Dev.
3:322008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen J, Park CS and Tang SJ:
Activity-dependent synaptic Wnt release regulates hippocampal long
term potentiation. J Biol Chem. 281:11910–11916. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Datta S, Chatterjee K, Kline RH IV and
Wiley RG: Behavioral and anatomical characterization of the
bilateral sciatic nerve chronic constriction (bCCI) injury:
Correlation of anatomic changes and responses to cold stimuli. Mol
Pain. 6:72010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hargreaves K, Dubner R, Brown F, Flores C
and Joris J: A new and sensitive method for measuring thermal
nociception in cutaneous hyperalgesia. Pain. 32:77–88. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gangadhar M, Mishra RK, Sriram D and
Yogeeswari P: Future directions in the treatment of neuropathic
pain: A review on various therapeutic targets. CNS Neurol Disord
Drug Targets. 13:63–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mohammed MK, Shao C, Wang J, Wei Q, Wang
X, Collier Z, Tang S, Liu H, Zhang F, Huang J, et al: Wnt/β-catenin
signaling plays an ever-expanding role in stem cell self-renewal,
tumorigenesis and cancer chemoresistance. Genes Dis. 3:11–40. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: Diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hering H and Sheng M: Direct interaction
of Frizzled-1, −2, −4, and −7 with PDZ domains of PSD-95. FEBS
Lett. 521:185–189. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Verkaar F and Zaman GJ: New avenues to
target Wnt/β-catenin signaling. Drug Discov Today. 16:35–41. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cerpa W, Toledo EM, Varela-Nallar L and
Inestrosa NC: The role of Wnt signaling in neuroprotection. Drug
News Perspect. 22:579–591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Wang X, Lu CC, Kerman R, Steward O,
Xu XM and Zou Y: Repulsive Wnt signaling inhibits axon regeneration
after CNS injury. J Neurosci. 28:8376–8382. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Suh HI, Min J, Choi KH, Kim SW, Kim KS and
Jeon SR: Axonal regeneration effects of Wnt3a-secreting fibroblast
transplantation in spinal cord-injured rats. Acta Neurochir (Wien).
153:1003–1010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yuan S, Shi Y and Tang SJ: Wnt signaling
in the pathogenesis of multiple sclerosis-associated chronic pain.
J Neuroimmune Pharmacol. 7:904–913. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang YK, Huang ZJ, Liu S, Liu YP, Song AA
and Song XJ: WNT signaling underlies the pathogenesis of
neuropathic pain in rodents. J Clin Invest. 123:2268–2286. 2013.
View Article : Google Scholar : PubMed/NCBI
|
